Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BSX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Susan E. Morano Director | BSX Boston Scientific Corporation | Buy | 2,040 | $49.22 | $100.4K Buy | Form 4 ↗ |
| Aug 5, 2026 | David C. Habiger Director | BSX Boston Scientific Corporation | Buy | 2,100 | $47.59 | $99.9K Buy | Form 4 ↗ |
| Aug 4, 2026 | David C. Habiger Director | BSX Boston Scientific Corporation | Buy | 140 | $48.59 | $6,803 Buy | Form 4 ↗ |
| Aug 3, 2026 | David C. Habiger Director | BSX Boston Scientific Corporation | Buy | 1,042 | $48.07 | $50.1K Buy | Form 4 ↗ |
| Aug 3, 2026 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Buy | 186,240 | $48.33 | $9.0M Buy | Form 4 ↗ |
| Jul 31, 2026 | Edward J. Ludwig Director | BSX Boston Scientific Corporation | Buy | 5,000 | $45.48 | $227.4K Buy | Form 4 ↗ |
| May 20, 2026 | Cheryl Pegus Director | BSX Boston Scientific Corporation | Buy | 1,770 | $56.49 | $100.0K Buy | Form 4 ↗ |
| May 20, 2026 | Edward J. Ludwig Director | BSX Boston Scientific Corporation | Buy | 3,580 | $56.68 | $202.9K Buy | Form 4 ↗ |
| May 20, 2026 | David C. Habiger Director | BSX Boston Scientific Corporation | Buy | 2,250 | $55.92 | $125.8K Buy | Form 4 ↗ |
| May 19, 2026 | David C. Habiger Director | BSX Boston Scientific Corporation | Buy | 2,200 | $56.95 | $125.3K Buy | Form 4 ↗ |
| Feb 2, 2026 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 159,701 | $93.49 | $14.9M Sale | Form 4 ↗ |
| Feb 2, 2026 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 1,200 | $94.06 | $112.9K Sale | Form 4 ↗ |
| Dec 1, 2025 | Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | BSX Boston Scientific Corporation | Sale | 17,313 | $101.55 | $1.8M Sale | Form 4 ↗ |
| Nov 6, 2025 | Ellen M. Zane Director | BSX Boston Scientific Corporation | Sale | 12,891 | $98.28 | $1.3M Sale | Form 4 ↗ |
| Nov 3, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 29,472 | $99.14 | $2.9M Sale | Form 4 ↗ |
| Nov 3, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 16,928 | $99.76 | $1.7M Sale | Form 4 ↗ |
| Nov 3, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 3,600 | $100.75 | $362.7K Sale | Form 4 ↗ |
| Oct 28, 2025 | Ellen M. Zane Director | BSX Boston Scientific Corporation | Sale | 2,901 | $102.24 | $296.6K Sale | Form 4 ↗ |
| Oct 27, 2025 | Ellen M. Zane Director | BSX Boston Scientific Corporation | Sale | 9,990 | $101.13 | $1.0M Sale | Form 4 ↗ |
| Oct 1, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 41,755 | $98.38 | $4.1M Sale | Form 4 ↗ |
| Oct 1, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 8,245 | $98.91 | $815.5K Sale | Form 4 ↗ |
| Sep 2, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 28,170 | $105.85 | $3.0M Sale | Form 4 ↗ |
| Sep 2, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 21,830 | $104.89 | $2.3M Sale | Form 4 ↗ |
| Aug 1, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 50,000 | $104.63 | $5.2M Sale | Form 4 ↗ |
| Aug 1, 2025 | Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | BSX Boston Scientific Corporation | Sale | 17,313 | $104.63 | $1.8M Sale | Form 4 ↗ |
| Jul 29, 2025 | Yoshiaki Fujimori Director | BSX Boston Scientific Corporation | Sale | 2,901 | $106.99 | $310.4K Sale | Form 4 ↗ |
| Jul 25, 2025 | Edward J. Ludwig Director | BSX Boston Scientific Corporation | Sale | 4,000 | $106.03 | $424.1K Sale | Form 4 ↗ |
| Jul 1, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 50,000 | $106.97 | $5.3M Sale | Form 4 ↗ |
| Jun 4, 2025 | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | BSX Boston Scientific Corporation | Sale | 56,372 | $102.88 | $5.8M Sale | Form 4 ↗ |
| Jun 2, 2025 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 89,921 | $103.39 | $9.3M Sale | Form 4 ↗ |
| Jun 2, 2025 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 74,522 | $104.05 | $7.8M Sale | Form 4 ↗ |
| May 29, 2025 | Edward J. Ludwig Director | BSX Boston Scientific Corporation | Sale | 4,000 | $104.59 | $418.4K Sale | Form 4 ↗ |
| May 21, 2025 | Vance R. Brown SVP, GC and Corp. Secretary | BSX Boston Scientific Corporation | Sale | 4,826 | $106.42 | $513.6K Sale | Form 4 ↗ |
| May 5, 2025 | John Bradley Sorenson EVP, Global Operations | BSX Boston Scientific Corporation | Sale | 4,572 | $104.54 | $478.0K Sale | Form 4 ↗ |
| May 1, 2025 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 91,282 | $102.13 | $9.3M Sale | Form 4 ↗ |
| May 1, 2025 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 73,161 | $102.92 | $7.5M Sale | Form 4 ↗ |
| May 1, 2025 | Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | BSX Boston Scientific Corporation | Sale | 17,314 | $102.06 | $1.8M Sale | Form 4 ↗ |
| Apr 21, 2025 | Vance R. Brown SVP, GC and Corp. Secretary | BSX Boston Scientific Corporation | Sale | 4,826 | $95.09 | $458.9K Sale | Form 4 ↗ |
| Apr 1, 2025 | Michael F. Mahoney Chairman, President & CEO, Director | BSX Boston Scientific Corporation | Sale | 164,442 | $100.01 | $16.4M Sale | Form 4 ↗ |
| Mar 21, 2025 | Vance R. Brown SVP, GC and Corp. Secretary | BSX Boston Scientific Corporation | Sale | 4,826 | $100.85 | $486.7K Sale | Form 4 ↗ |
| Mar 4, 2025 | Emily Woodworth SVP, Global Controller and CAO | BSX Boston Scientific Corporation | Sale | 482 | $104.63 | $50.4K Sale | Form 4 ↗ |
| Mar 3, 2025 | Emily Woodworth SVP, Global Controller and CAO | BSX Boston Scientific Corporation | Sale | 7,149 | $104.97 | $750.4K Sale | Form 4 ↗ |
| Feb 28, 2025 | Emily Woodworth SVP, Global Controller and CAO | BSX Boston Scientific Corporation | Sale | 9,887 | $101.13 | $999.9K Sale | Form 4 ↗ |
| Feb 25, 2025 | Jeffrey B. Mirviss EVP&Pres, Periph Intervent | BSX Boston Scientific Corporation | Sale | 2,688 | $104.00 | $279.6K Sale | Form 4 ↗ |
| Feb 24, 2025 | Jeffrey B. Mirviss EVP&Pres, Periph Intervent | BSX Boston Scientific Corporation | Sale | 4,675 | $104.25 | $487.4K Sale | Form 4 ↗ |
| Feb 24, 2025 | Ellen M. Zane Director | BSX Boston Scientific Corporation | Sale | 13,586 | $104.23 | $1.4M Sale | Form 4 ↗ |
| Feb 21, 2025 | Vance R. Brown SVP, GC and Corp. Secretary | BSX Boston Scientific Corporation | Sale | 4,826 | $104.64 | $505.0K Sale | Form 4 ↗ |
| Feb 19, 2025 | John Bradley Sorenson EVP, Global Operations | BSX Boston Scientific Corporation | Sale | 3,303 | $105.19 | $347.4K Sale | Form 4 ↗ |
| Feb 19, 2025 | Jeffrey B. Mirviss EVP&Pres, Periph Intervent | BSX Boston Scientific Corporation | Sale | 1,510 | $105.35 | $159.1K Sale | Form 4 ↗ |
| Feb 19, 2025 | Daniel J. Brennan EVP and CFO | BSX Boston Scientific Corporation | Sale | 67,333 | $105.24 | $7.1M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances